FORWARD GLOBAL for QUOIN PHARMACEUTICALS, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEAH CHARETTE | — |
| AVA COFIELL | — |
| NOE GARCIA | — |
Medical/Disease Research/Clinical Labs MED
Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEAH CHARETTE | — |
| AVA COFIELL | — |
| NOE GARCIA | — |
Pharmacy PHA
Lobbying for continued funding from the government for rare disease research and development, including through the Rare Pediatric Disease Designation and Priority Review Voucher Programs; advocating for greater awareness about the rare disease community for doctors via the Give Kids a Chance Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEAH CHARETTE | — |
| AVA COFIELL | — |
| NOE GARCIA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.